Rick Doblin

Rick Doblin recently received his Ph.D. in Public Policy from Harvard University, with a dissertation focused on the regulation of the medical uses of psychedelics and marijuana.

Rick is the founder and president of the Multidisciplinary Association for Psychedelic Studies in Sarasota, Florida. M.A.P.S. is a scientific and educational non-profit organization chartered to foster medical and scientific research on psychoactive drugs, primarily MDMA.

Rick was also the co-founder and president of the Earth Metabolic Design Laboratory, a scientific and educational non-profit organization which coordinated testimony of medical and scientific community before a Drug Enforcement Administration Administrative Law Judge in support of efforts to place MDMA in Schedule 3.

Rick's publications include:

  • "Leary's Concord Prison Experiment- A 34-Year Follow-Up Study." J. Psychoactive Drugs, 30 (4), 1998.

  • "Survey Research vs Clinical Trials in Evaluating the Medical Utility of Marijuana" with Mark Kleiman, Southern Med. J 91 (10), 1998.

  • "The Medical Use of Marijuana: The Case for Clinical Trials", with Dr. Mark Kleiman, Journal of Addictive Diseases, Vol. 14 (1), 1995.

  • "The Good Friday Experiment: A Follow-Up", Journal of Transpersonal Psychology, August,1991.

  • "Marijuana as Antiemetic Medicine",with Dr. Mark Kleiman , Journal of Clinical Oncology, July 1,1991

  • "The Medical Use of Marijuana", with Dr. Mark Kleiman, letter in Annals of Internal Medicine, May 1,1991.

  • "The Rescheduling of Marijuana ", International Journal on Drug Policy, 1 (4) January-February, 1990.

  • "MDMA - Risk Assessment and the FDA" , Ecstasy - The MDMA Story, Bruce Eisner, Ronin Press, 1989.

Rick joined the CCLE's Board of Advisors in 2000.